container closure integrity testing

Market Access

At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants.

News

City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.